-+ 0.00%
-+ 0.00%
-+ 0.00%

SILO PHARMA REPORTS POSITIVE STABILITY DATA FOR SPC-15 PTSD TREATMENT, ADVANCING PROGRAM TOWARD FIRST-IN-HUMAN CLINICAL TRIAL

Reuters·06/23/2026 12:17:00

Please log in to view news